These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35037404)

  • 21. Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems.
    Hamilton FW; Gregson FKA; Arnold DT; Sheikh S; Ward K; Brown J; Moran E; White C; Morley AJ; ; Bzdek BR; Reid JP; Maskell NA; Dodd JW
    Thorax; 2022 Mar; 77(3):276-282. PubMed ID: 34737195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimum Sizes of Respiratory Particles Carrying SARS-CoV-2 and the Possibility of Aerosol Generation.
    Lee BU
    Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
    Yan J; Grantham M; Pantelic J; Bueno de Mesquita PJ; Albert B; Liu F; Ehrman S; Milton DK;
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1081-1086. PubMed ID: 29348203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
    Sawano M; Takeshita K; Ohno H; Oka H
    J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.
    Schijven J; Vermeulen LC; Swart A; Meijer A; Duizer E; de Roda Husman AM
    Environ Health Perspect; 2021 Apr; 129(4):47002. PubMed ID: 33793301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need.
    Stakenborg T; Raymenants J; Taher A; Marchal E; Verbruggen B; Roth S; Jones B; Yurt A; Duthoo W; Bombeke K; Fauvart M; Verplanken J; Wiederkehr RS; Humbert A; Dang C; Vlassaks E; Jáuregui Uribe AL; Luo Z; Liu C; Zinoviev K; Labie R; Frederiks AD; Saldien J; Covens K; Berden P; Schreurs B; Van Duppen J; Hanifa R; Beuscart M; Pham V; Emmen E; Dewagtere A; Lin Z; Peca M; El Jerrari Y; Nawghane C; Arnett C; Lambrechts A; Deshpande P; Lagrou K; De Munter P; André E; Van den Wijngaert N; Peumans P
    Biosens Bioelectron; 2022 Dec; 217():114663. PubMed ID: 36150327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of exhaled breath particles from healthy and human rhinovirus-infected subjects.
    Fabian P; Brain J; Houseman EA; Gern J; Milton DK
    J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):137-47. PubMed ID: 21361786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients.
    Li YH; Fan YZ; Jiang L; Wang HB
    Epidemiol Infect; 2020 Jul; 148():e154. PubMed ID: 32660668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza A and B Viruses in Fine Aerosols of Exhaled Breath Samples from Patients in Tropical Singapore.
    Chow VTK; Tay DJW; Chen MIC; Tang JW; Milton DK; Tham KW
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities.
    Ong SWX; Tan YK; Coleman KK; Tan BH; Leo YS; Wang DL; Ng CG; Ng OT; Wong MSY; Marimuthu K
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1327-1332. PubMed ID: 33487210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurements of airborne influenza virus in aerosol particles from human coughs.
    Lindsley WG; Blachere FM; Thewlis RE; Vishnu A; Davis KA; Cao G; Palmer JE; Clark KE; Fisher MA; Khakoo R; Beezhold DH
    PLoS One; 2010 Nov; 5(11):e15100. PubMed ID: 21152051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viable influenza A virus in airborne particles expelled during coughs versus exhalations.
    Lindsley WG; Blachere FM; Beezhold DH; Thewlis RE; Noorbakhsh B; Othumpangat S; Goldsmith WT; McMillen CM; Andrew ME; Burrell CN; Noti JD
    Influenza Other Respir Viruses; 2016 Sep; 10(5):404-13. PubMed ID: 26991074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling aerosol transmission of SARS-CoV-2 from human-exhaled particles in a hospital ward.
    Saw LH; Leo BF; Nor NSM; Yip CW; Ibrahim N; Hamid HHA; Latif MT; Lin CY; Nadzir MSM
    Environ Sci Pollut Res Int; 2021 Oct; 28(38):53478-53492. PubMed ID: 34036501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19.
    Malik M; Kunze AC; Bahmer T; Herget-Rosenthal S; Kunze T
    Int J Infect Dis; 2021 Sep; 110():105-110. PubMed ID: 34242768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative evaluation of aerosol generation during tracheal intubation and extubation.
    Brown J; Gregson FKA; Shrimpton A; Cook TM; Bzdek BR; Reid JP; Pickering AE
    Anaesthesia; 2021 Feb; 76(2):174-181. PubMed ID: 33022093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol Dynamics Model for Estimating the Risk from Short-Range Airborne Transmission and Inhalation of Expiratory Droplets of SARS-CoV-2.
    Dhawan S; Biswas P
    Environ Sci Technol; 2021 Jul; 55(13):8987-8999. PubMed ID: 34132519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March-May 2020.
    Lane MA; Brownsword EA; Babiker A; Ingersoll JM; Waggoner J; Ayers M; Klopman M; Uyeki TM; Lindsley WG; Kraft CS
    Clin Infect Dis; 2021 Oct; 73(7):e1790-e1794. PubMed ID: 33506256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: Implications in understanding SARS-CoV2 transmission.
    Sriraman K; Shaikh A; Parikh S; Udupa S; Chatterjee N; Shastri J; Mistry N
    PLoS One; 2021; 16(4):e0249525. PubMed ID: 33844696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Experimental and Clinical Bioaerosol Generation During Potential Aerosol-Generating Procedures.
    Doggett N; Chow CW; Mubareka S
    Chest; 2020 Dec; 158(6):2467-2473. PubMed ID: 32707180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load.
    Tomisa G; Horváth A; Farkas Á; Nagy A; Kis E; Tamási L
    J Hosp Infect; 2021 Dec; 118():7-14. PubMed ID: 34487775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.